Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2681

Actual shortage: 255 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2417 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

23 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
CEFOXITIN FOR INJECTION 10G POWDER FOR SOLUTION Resolved 2019-06-13 2020-05-14 86614
CEFOXITIN FOR INJECTION 2G POWDER FOR SOLUTION Resolved 2019-06-18 2019-07-15 86969
CEFOXITIN FOR INJECTION 1G POWDER FOR SOLUTION Resolved 2019-06-27 2020-02-07 87662
CEFOXITIN FOR INJECTION 2G POWDER FOR SOLUTION Resolved 2019-08-22 2020-02-07 92177
CEFOXITIN FOR INJECTION 2G POWDER FOR SOLUTION Resolved 2021-09-30 2021-10-07 146440
CEFTRIAXONE SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Resolved 2019-06-18 2019-07-15 86972
CEFTRIAXONE SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Resolved 2021-01-07 2021-02-12 131093
CINQAIR 10MG SOLUTION Resolved 2020-05-08 2020-09-03 114421
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2019-06-27 2019-08-29 87665
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2019-11-07 2020-05-29 98188
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2021-01-15 2021-05-06 131691
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2021-02-05 2021-04-29 133457
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2021-06-24 2021-07-09 141469
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2023-04-27 2023-06-09 190671
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2023-06-16 2023-08-18 195121
DOCETAXEL INJECTION 20MG SOLUTION Actual shortage 2017-03-13 2017-10-05 1680
DOCETAXEL INJECTION 80MG SOLUTION Actual shortage 2017-03-13 2017-10-05 1688
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2018-06-22 2018-10-11 52823
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-10-10 95373
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-10-10 95378

Showing 341 to 360 of 2681

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-QUININE 200MG CAPSULE Discontinued 2020-10-08 2020-10-09 125976
TEVA-RABEPRAZOLE EC 20MG TABLET (DELAYED-RELEASE) Discontinued 2020-07-10 2020-07-10 120015
TEVA-RABEPRAZOLE EC 10MG TABLET (DELAYED-RELEASE) Discontinued 2020-07-10 2020-07-10 120018
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
TEVA-RANITIDINE SOLUTION 15MG SOLUTION Discontinued 2019-04-11 2019-04-11 81304
TEVA-RISEDRONATE 150MG TABLET Discontinued 2021-02-12 2021-02-12 133905
TEVA-ROSUVASTATIN 5MG TABLET Discontinued 2022-03-25 2022-03-26 157428
TEVA-ROSUVASTATIN 10MG TABLET Discontinued 2022-03-25 2022-03-26 157431
TEVA-ROSUVASTATIN 20MG TABLET Discontinued 2022-03-25 2022-03-26 157434
TEVA-ROSUVASTATIN 40MG TABLET Discontinued 2022-03-25 2022-03-26 157437
TEVA-TECNAL C 1/4 330MG 50MG 15MG 40MG CAPSULE Discontinued 2019-04-11 2019-04-11 81353
TEVA-TRANDOLAPRIL 0.5MG CAPSULE Discontinued 2020-07-10 2020-07-10 120021
TEVA-TRANDOLAPRIL 1MG CAPSULE Discontinued 2020-07-10 2020-07-10 120024
TEVA-TRANDOLAPRIL 2MG CAPSULE Discontinued 2020-07-10 2020-07-10 120027
TEVA-TRANDOLAPRIL 4MG CAPSULE Discontinued 2020-07-10 2020-07-10 120030
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION 0.004% SOLUTION Discontinued 2020-01-21 2020-01-21 103788
TEVA-TRIAMTERENE/HCTZ 25MG 50MG TABLET Discontinued 2017-06-27 2017-06-27 14060
TEVA-TRIAMTERENE/HCTZ 50MG 25MG TABLET Discontinued 2020-05-14 2020-05-14 115091
TEVA-TRIMEL 400MG 80MG TABLET Discontinued 2018-10-19 2018-10-19 65017

Showing 221 to 240 of 250